Virology

Instituto de Medicina Tropical “Alexander von Humboldt” IMTAvH of the Universidad Peruana Cayetano Heredia (UPCH): The Institute of Tropical Medicine “Alexander von Humboldt” of the Universidad Peruana Cayetano Heredia, founded in 1968 by Dr. Hugo Lumbreras, is the leading research center in infectious and tropical diseases in Peru. We are a multidisciplinary Institute specialized in infectious and tropical diseases, with global leadership that conducts innovative research; promotes public policies and technology transfer, contributing to the country’s development. We believe that delivering patient care is insufficient to fight against tropical diseases; therefore, we also prioritize training, research and clinical care. This thorough approach has allowed the continuous interaction of physicians and researchers towards prevention, control, the development of diagnostic tests, molecular biology and global health, prioritizing remote rural populations. Currently we have 8 research groups and 12 laboratories (complete list seen below) which bring together faculties from the School of Medicine, Science, Public Health, Veterinary medicine, Dentistry and Nursing which collaborate with national and international institutions in the development of teaching and training activities on infectious and tropical diseases.

The University of Texas Medical Branch (UTMB) is known worldwide for its academic excellence in virology research. The scientists and academic staff at the university include some of the world’s foremost infectious disease experts, and research at the university results in groundbreaking biomedical discoveries and the development of vaccines, therapeutics and diagnostic tools. The Galveston National Laboratory (GNL), the flagship high containment facility of the UTMB Institute of Human Infections and Immunity, resides on the UTMB campus and houses research on Ebola, chikungunya, MERS coronavirus, dengue, West Nile, and other emerging viruses. The Institute also includes the Center for Biodefense & Emerging Infectious Diseases, the Sealy Center for Vaccine Development, the Center for Tropical Diseases, and the McLaughlin Endowment for Infection and Immunity.